AlphaTON Capital Corp.(ALP)

盘后0.18450.00+0.82%19:59 EDT

0.1830-0.0470-20.43%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- Alphaton Capital Corp：品牌重塑不影响公司架构、法律注册地及现有合同义务
  美股速递 · 04-20
  Alphaton Capital Corp：品牌重塑不影响公司架构、法律注册地及现有合同义务
公司概况
公司名称
AlphaTON Capital Corp.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.portagebiotech.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
AlphaTON Capital Corp于1973年在安大略省注册成立。AlphaTON是一家临床阶段的免疫肿瘤学公司，该公司认为这将是一流的疗法，针对已知的检查点耐药途径，以改善长期治疗反应和生活质量的患者回避癌症。AlphaTON目前正在研究9项免疫肿瘤学资产，其中5项处于临床前阶段，4项处于临床阶段。AlphaTON药物开发管道产品包括基于生物学的候选产品或技术，以确定的科学原理解决当前检查点抑制剂的已知耐药途径/机制，包括肿瘤内递送、纳米颗粒、脂质体、适体和病毒样颗粒。

分时
5日
日
周
月

数据加载中...

最高

0.2080

今开

0.2080

量比

0.35

最低

0.1760

昨收

0.2300

换手率

74.00%

热议股票

{"pagemeta":{"title":"AlphaTON Capital Corp.(ALP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供AlphaTON Capital Corp.(ALP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"AlphaTON Capital Corp.,ALP,AlphaTON Capital Corp.股票,AlphaTON Capital Corp.股票老虎,AlphaTON Capital Corp.股票老虎国际,AlphaTON Capital Corp.行情,AlphaTON Capital Corp.股票行情,AlphaTON Capital Corp.股价,AlphaTON Capital Corp.股市,AlphaTON Capital Corp.股票价格,AlphaTON Capital Corp.股票交易,AlphaTON Capital Corp.股票购买,AlphaTON Capital Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"AlphaTON Capital Corp.(ALP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供AlphaTON Capital Corp.(ALP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"news","symbol":"ALP","data":{"stockData":{"symbol":"ALP","market":"US","secType":"STK","nameCN":"AlphaTON Capital Corp.","latestPrice":0.183,"timestamp":1776974400000,"preClose":0.23,"halted":0,"volume":16306230,"hourTrading":{"tag":"盘后","latestPrice":0.1845,"preClose":0.183,"latestTime":"19:59 EDT","volume":1632766,"amount":308063.822581,"timestamp":1776988795648,"change":0.0015,"changeRate":0.008197,"amplitude":0.153005},"delay":0,"changeRate":-0.20434782608695656,"floatShares":22036600,"shares":23434600,"eps":-8.573978,"marketStatus":"未开盘","change":-0.047,"latestTime":"04-23 16:00:00 EDT","open":0.208,"high":0.208,"low":0.176001,"amount":3148841.7755541,"amplitude":0.139126,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-8.573978,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777017600000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.23,"preHourTrading":{"tag":"盘前","latestPrice":0.208,"preClose":0.23,"latestTime":"09:29 EDT","volume":2040768,"amount":426455.53394687996,"timestamp":1776950966817,"change":-0.022,"changeRate":-0.095652,"amplitude":0.076087},"postHourTrading":{"tag":"盘后","latestPrice":0.1845,"preClose":0.183,"latestTime":"19:59 EDT","volume":1632766,"amount":308063.822581,"timestamp":1776988795648,"change":0.0015,"changeRate":0.008197,"amplitude":0.153005},"volumeRatio":0.345242},"tweetData":null,"newsData":{"listData":[{"id":"1137620207","title":"Alphaton Capital Corp：品牌重塑不影响公司架构、法律注册地及现有合同义务","url":"https://stock-news.laohu8.com/highlight/detail?id=1137620207","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137620207?lang=zh_cn&edition=full","pubTime":"2026-04-20 19:34","pubTimestamp":1776684854,"startTime":"0","endTime":"0","summary":"Alphaton Capital Corp近日宣布，公司进行的品牌重塑行动不会对其现有企业结构、法律注册地址或任何正在履行的合约责任产生变更。\n此次品牌更新仅涉及企业形象与市场标识的优化，所有运营实体、股权关系及法律义务均保持原有状态。公司强调，此举旨在提升品牌认知度，不会触发组织架构调整或合同条款修订。\n客户、合作伙伴及投资者可继续依据原有法律文件与公司开展业务，所有既定的权利与义务关系不受本次品牌焕新影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATON","ALP"],"isVideo":false,"video":null,"gpt_icon":0}],"currentPage":1,"bottom":true},"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":{"websiteUrl":"http://www.portagebiotech.com","stockEarnings":[{"period":"1week","weight":-0.4301},{"period":"1month","weight":-0.4671},{"period":"3month","weight":-0.7297},{"period":"6month","weight":-0.9643},{"period":"1year","weight":-0.9796},{"period":"ytd","weight":-0.695}],"compareEarnings":[{"period":"1week","weight":0.0097},{"period":"1month","weight":0.0846},{"period":"3month","weight":0.0279},{"period":"6month","weight":0.0461},{"period":"1year","weight":0.3232},{"period":"ytd","weight":0.0389}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"AlphaTON Capital Corp于1973年在安大略省注册成立。AlphaTON是一家临床阶段的免疫肿瘤学公司，该公司认为这将是一流的疗法，针对已知的检查点耐药途径，以改善长期治疗反应和生活质量的患者回避癌症。AlphaTON目前正在研究9项免疫肿瘤学资产，其中5项处于临床前阶段，4项处于临床阶段。AlphaTON药物开发管道产品包括基于生物学的候选产品或技术，以确定的科学原理解决当前检查点抑制剂的已知耐药途径/机制，包括肿瘤内递送、纳米颗粒、脂质体、适体和病毒样颗粒。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.1663},{"month":2,"riseRate":0.2,"avgChangeRate":-0.198741},{"month":3,"riseRate":0.166667,"avgChangeRate":0.038631},{"month":4,"riseRate":0.5,"avgChangeRate":-0.127527},{"month":5,"riseRate":0.6,"avgChangeRate":0.296277},{"month":6,"riseRate":0.2,"avgChangeRate":-0.284423},{"month":7,"riseRate":0.4,"avgChangeRate":0.000618},{"month":8,"riseRate":0.4,"avgChangeRate":0.017196},{"month":9,"riseRate":0.4,"avgChangeRate":0.075522},{"month":10,"riseRate":0.2,"avgChangeRate":-0.056477},{"month":11,"riseRate":0,"avgChangeRate":-0.320667},{"month":12,"riseRate":0.4,"avgChangeRate":-0.090161}],"exchange":"NASDAQ","name":"AlphaTON Capital Corp.","nameEN":"AlphaTON Capital Corp."},"aProfile":null}}}